Emer Cooke takes office as head of EMA
News
Corporate
Antimicrobial resistance
Innovation
Emer Cooke has begun her mandate as Executive Director of the European Medicines Agency today, 16 November 2020.
Ms Cooke was nominated as Executive Director with a renewable five-year mandate by the Agency’s Management Board on 25 June 2020 and is the first woman at the helm of EMA. She was appointed following her statement to the European Parliament's Committee on Environment, Public Health and Food Safety (ENVI) on 13 July 2020.
“I take up the role of Executive Director of EMA amid a public health crisis of unprecedented scale,” said Emer Cooke on her first day in office. “My number one priority will be to drive forward EMA’s response to the pandemic and the work already ongoing to support the development and approval of safe and effective COVID-19 vaccines and treatments.”
She stressed that the Agency will also have to tackle other major challenges, including antibiotic resistance, supporting new waves of innovation and making the most of the opportunities provided by digitalisation for medicine discovery and development.
“Last week’s announcement of the expansion of EMA’s mandate is an acknowledgement of the trust in our ability to deliver. I look forward to working with the EU regulatory network, the European Commission, and regulators globally, to address these issues and to further promote human and animal health,” she added.
Emer Cooke also takes over the chairperson position at the International Coalition of Medicines Regulatory Authorities (ICMRA), which is currently led by EMA.
Notes